Barwis Methods Becomes Exclusive Sales Representative of Renew® ECP for the Sports and Rehabilitation Marketplaces
FARMINGTON HILLS, Mich., June 30, 2016 /PRNewswire/ -- LifeLine Sciences, LLC today announced that the company has reached an exclusive sales agreement with professional sports training company Barwis Methods to sell Renew® ECP in the Sports and Physical Rehab market place. Renew® ECP is ideally suited to support clinician goals of efficient and effective recovery which may contribute to performance enhancement for athletes and highly active individuals.
"Scientific research1,2 shows that Renew® ECP stimulates the nitric oxide cycle, through flow-mediated vasodilation, which could aid in decreased muscle inflammation and recovery from delayed-onset muscle soreness in athletes. We believe Renew® ECP may also help promote recovery from muscle damage," said Mike Barwis, CEO & Founder, Barwis Methods. Studies have shown that this type of treatment may also assist in maintaining cardiovascular conditioning and fitness during periods of rehabilitation3. The use of Renew® ECP in therapy contributes to vasodilation which may help improve blood flow throughout the body4.
"We are thrilled to work with Barwis Methods to bring the many benefits of Renew® ECP in therapy to athletes," said Bill Featherstone, CCO, Lifeline Sciences. "We know that this treatment may have a significant impact on athletic performance, and we couldn't ask for a better partner to represent the Renew brand in the sport and recovery markets."
For more information on how the Renew® NCP-5 can help you take your training to the next level, please contact – Drew Collins, either by e-mail at [email protected] or phone at (517) 442-6174.
Renew® ECP is an FDA cleared prescription device that increases blood flow, vasodilation, and VO2 by enhancing blood flow throughout the body. During treatment, the patient's legs are compressed by pneumatic cuffs in precise coordination with the cardiac cycle. When the heart is at rest, this compression forces blood back to the heart and throughout the entire vascular system. This "counterpulsation" acts as an auxiliary pump benefitting the entire cardiovascular system and has been clinically proven to improve an individual's tolerance for activity.5,6.
LifeLine Sciences, LLC is a sales and marketing company in North America. The company currently sells Renew® NCP-5 External Counterpulsation device.
Barwis Methods is a Professional Grade Sports Training company founded by Mike Barwis, with locations throughout Michigan, Florida and California. Mike Barwis was formerly the Director of Strength & Conditioning at West Virginia University and the University of Michigan, and has over 20 years of industry experience. Since its inception, Barwis Methods has trained over 625 Olympic and professional athletes in more than 40 sporting events, including teams such as the New York Mets, Miami Dolphins, and the Detroit Red Wings. In addition to working with athletes, Barwis Methods also provides specialized Neurological Reengineering training, developed by Mike Barwis, to individuals with spinal cord injuries, cerebral palsy, multiple sclerosis, cancers, strokes, and any disorder affecting the neuromuscular system.
Renew is a registered trademark of Renew Group Private Limited.
1 Alvaro N Gurovich and Randy W Braith, Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans, Hypertension Research (2013) 36, 297–305; doi:10.1038/hr.2012.169; published online 18 October 2012.
2 Carly R. Catanese, Effect Of External Counterpulsation (Ecp) On Delayed Onset Muscle Soreness (Doms) In Long Distance Runners, Cleveland State University, 2007.
3 Barsness G, Feldman A, Holmes DR, Jr, Holubkov R, Kelsey SF, Kennard ED, The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results, Clinical Cardiology, 2001;24(6):435-42.
4 M. J. Hilz, D. Werner, H. Marthol, F. A. Flachskampf and W. G. Daniel, Enhanced external counterpulsation improves skin oxygenation and perfusion, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany, and New York University School of Medicine, New York, NY
5 Grayson, D.; de Jong, Adam; Ochoa, Anthony; Gallagher, Michael; Franklin, Barry FACSM; McCullough, Peter A., Oxygen Consumption Changes During EECP Treatment in Patients with and without Disease Coronary Art. Medicine & Science in Sports & Exercise:May 2004 - Volume 36 - Issue 5 - p S214, Annual Meeting Abstracts: E-32 - Free Communication/Poster: Exercise and Cardiovascular Disease.
6 Arora RR, et al. Effects of Enhanced External Counterpulsation on Health-Related Quality of Life Continue 12 Months After Treatment: A Substudy of the Multicenter Study of Enhanced External Counterpulsation. Journal of Investigative Medicine. 2002;50:25-32.
Contact:
Melissa Skabich
PCE Communications, LLC
973-760-9926
[email protected]
SOURCE LifeLine Sciences, LLC
Share this article